![Sin imagen](https://static.cymitquimica.com/public/img/logo-cymit-gray.png)
CAS: 1286279-29-5
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
![]() | BMS-813160 REF: TM-T4584CAS: 1286279-29-5 | 99.66% - 99.78% | 63,00 €~1.644,00 € | Mar 11 Mar 25 |
![]() | BMS 813160 REF: 3D-BB164193CAS: 1286279-29-5 | Min. 95% | 348,00 €~1.672,00 € | Mar 15 Abr 25 |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
BMS-813160
CAS:1286279-29-5
BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for cardiovascular.
Fórmula:
C25H40N8O2
Pureza:
99.66% - 99.78%
Forma y color:
Solid
Peso molecular:
484.64
Ref: TM-T4584
1mg | 63,00 € | ||
5mg | 137,00 € | ||
10mg | 187,00 € | ||
25mg | 341,00 € | ||
50mg | 567,00 € | ||
100mg | 810,00 € | ||
500mg | 1.644,00 € | ||
1mL*10mM (DMSO) | 145,00 € |
Entrega estimada en Estados Unidos, el Martes 11 de Marzo de 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
BMS 813160
CAS:1286279-29-5
Antagonist of chemokine receptors CCR2 and CCR5
Fórmula:
C25H40N8O2
Pureza:
Min. 95%
Peso molecular:
484.64 g/mol
Ref: 3D-BB164193
1mg | 348,00 € | ||
5mg | 1.045,00 € | ||
10mg | 1.672,00 € |
Entrega estimada en Estados Unidos, el Martes 15 de Abril de 2025